Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2008.170 | Identification of Serum N-glycan Markers for the Diagnosis of Hepatocellular Carcinoma | Prof POON Chuen Wai |
| 2008.245 | A Shotgun Proteome Sequencing System for Human Proteome Projects - Deciphering the Global Protein Profiles of Diseased Livers | Prof POON Chuen Wai |
| 2010.179 | Identification of circulating antigens in patients with Helicobacter pylori infection | Prof. POON Chuen Wai |
| 2019.411 | The Excessive Mortality in Nasopharyngeal Carcinoma (NPC) Survivors ≥ 5 years |
Dr. POON Darren M.C. 潘明駿 |
| 2018.474 | Randomized phase II study of combination androgen deprivation therapy (ADT) and radiotherapy in high risk prostate cancer: Stereotactic body Radiotherapy vs conventionAl IMRT to prostate and pelvic nodes (SRAM study) | Dr. POON Darren M.C. |
| 2019.528 | Stratification of Indolent Versus Aggressive Prostate Cancer plus the Determination of Druggable Gene Targets for Aggressive Prostate Cancer: A Retrospective Study Using Archival Biopsy Samples | Dr. POON Darren M.C. |
| 2019.649 | PSMA-PET guided Stereotactic Ablative Body Radiotherapy for Oligometastasis in metastatic castration-resistant prostate cancer (mCRPC) with progression on Enzalutamide (PMSABR study) |
Dr. POON Darren MC 潘明駿 |
| 2020.055 | An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies | Dr. POON Darren Ming Chun |
| 2019.613 | A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (CheckMate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2019.333 | A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk |
Dr. POON Darren Ming Chun 潘明駿 |
| 2018.459 | Retrospective study of docetaxel-related neutropenic sepsis in metastatic hormonal-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2018.472 | A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined with Intravesical BCG in Participants with BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer (CheckMate 9UT: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9UT) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2011.603 | A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER | Dr. POON Darren Ming Chun |
| 2016.347 | Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-199) |
Dr. POON Darren Ming Chun 潘明駿醫生 |
| 2018.036 | A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877)compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinumcontaining chemotherapy |
Dr. POON Darren Ming Chun 潘明駿醫生 |
| 2016.302 | A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS MONOTHERAPY AND IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA |
Dr. POON Darren Ming Chun 潘明駿 |
| 2017.067 | Study on Epidemiology and Clinical Features of Patients Diagnosed with Nasopharyngeal Carcinoma at less than 20 years old in Hong Kong from 1993-2012 |
Dr. POON Darren Ming Chun 潘明駿 |
| 2019.630 | Survival Estimate Models of Cancer Patients with Spinal Metastases: Big Data Analytics to Aid Daily Clinical Practice |
Dr. POON Darren Ming Chun 潘明駿 |
| 2022.312 | Cardiovascular investigation of Coronavirus Disease 2019 (COVID-19) |
Prof. POON Ellen 潘雅欣 |
| 2024.410 | Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial |
Prof. POON Eric Tsz Chun Eric Tsz-chun Poon |
| 2024.355 | High-Intensity Interval Exercise and Low-Carbohydrate Diet for Glycaemic Control and Cardiovascular Fitness in Physically Inactive Adults with Prediabetes: A Comparative Randomised Trial |
Prof. POON Eric Tsz Chun 潘梓竣 |
| 2024.529 | An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial | Prof. POON Eric Tsz-chun |
| 2007.456 | An Uncontrolled Observational Study to Monitor Vascular Access on Haemodilaysis Patients in One Single Centre | RN Poon Ka Lai |
| 2023.538 | An investigation into levels of proteins/analytes in maternal blood using Lateral Flow Immunoassays (LTFs) and Point of Care Readers (POC) for Maternal and fetal complications of Pregnancy |
Prof. POON Liona Chiu Yee Chiu Yee Liona POON |
| 2020.690 | Prenatal neurosonography in monochorionic twins |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2022.340 | First-trimester screening and prevention of preeclampsia: prenatal and postpartum follow-up | Prof. POON Liona Chiu Yee |
| 2021.019 | An investigation of placenta in the role of aspirin resistance in preeclampsia prevention | Prof. POON Liona Chiu Yee |
| 2022.467 | Evaluation of first trimester screening performance and cost effectiveness | Prof. POON Liona Chiu Yee |
| 2022.446 | Innovative wearable blood pressure monitoring device for preeclampsia risk assessment and management | Prof. POON Liona Chiu Yee |
| 2022.445 | A point-of-care test for the measurement of placental growth factor for preeclampsia risk stratification | Prof. POON Liona Chiu Yee |
| 2021.395 | Prediction algorithms for preeclampsia for twin pregnancy | Prof. POON Liona Chiu Yee |
| 2021.249 | Labor induction versus expectant management in high-risk women for preeclampsia (FORECAST-IOL) | Prof. POON Liona Chiu Yee |
| 2021.247 | Integration of ultrasound into partogram for assessment of progress in labour |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2023.231 | The Application of Urine Specimen for Women Wellness | Prof. POON Liona Chiu Yee |
| 2022.034 | First-trimester preeclampsia screening: psychological impact on pregnant women throughout pregnancy |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2021.393 | A feasibility study on the use of cell-free DNA for prediction of preeclampsia |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2023.388 | Placental growth factor point-of-care testing to assess East Asian women with suspected preeclampsia: a randomized controlled trial | Prof. POON Liona Chiu Yee |
| 2022.154 | Outcomes of pregnant women with COVID-19 in Hong Kong | Prof. POON Liona Chiu Yee |
| 2023.559 | Validation of the Fetal Medicine Foundation first-trimester Bayes theorem-based model for the prediction of preeclampsia: an individual-patient-data meta-analysis (FMF-IPDMA) | Prof. POON Liona Chiu Yee |
| 2023.375 | Systematic characterization of microbiology and inflammatory response in preterm labor syndrome and other associated obstetrics condition | Prof. POON Liona Chiu Yee |
| 2021.406 | Aspirin versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial 早发型子痫前期高风险孕妇使用阿司匹林与二甲双胍的比较: 一项三臂随机对照试验 |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2020.468 | Pregnancy and Neonatal Outcomes in COVID-19: A global registry of women with suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates; understanding natural history to guide treatment and prevention |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.302 | Evaluation of aspirin non-responsiveness in preeclampsia prevention: a pharmacometabolomic approach |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2020.473 | Genome-wide cell-free DNA test for fetal chromosomal abnormalities and genomic aberrations |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2020.214 | COVID-19 seroconversion during pregnancy |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2020.245 | MIND-COVID: Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic – a web-based cross-sectional survey |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.622 | Genetics association and neurodevelopment in fetal congenital abnormalities |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2019.484 | Validation of Preeclampsia Detection kit (Point-of-Care test) |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.410 | Novel Technique for the Detection of Fetal Cells in Maternal Circulation |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2020.210 | Effect of coronavirus disease 2019 (COVID-19) on maternal and perinatal outcomes and risk of vertical transmission |
Prof. POON Liona Chiu Yee 潘昭頤 |
Page 189 of 265.